The initiation of the Phase 2 study in patients in the United Kingdom (UK) follows the successful completion of dosing in the Phase 1 study in healthy volunteers at the same clinical unit in the UK, allowing for a rapid transition to Phase 2.

During these challenging times, it’s important to celebrate good news and we are delighted to announce today that we have been honoured with The Queen’s Award for Enterprise in International Trade! The awards have been announced today, on Her Majesty The Queen’s 94th birthday, and The MEU is one of the 220 organisations nationally to […]

We’re looking forward to attending The 3rd Cystic Fibrosis Clinical Trials Meeting: Improving Access for All in Nottingham later this month. The event proposes a number of highly regarded UK and international speakers, and has been developed by the scientific committee to cover a broad range of stakeholders and to respond to the needs of […]